Precigen Inc
PGENHealthcare|Biotechnology|USA
$5.33
-0.21 (-3.80%)
Tangible Book
$0.01
About
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Stock Price
+178.8%(1Y)
Pipeline Summary
8 total trials6
Phase 1
3
Phase 2
0
Phase 3
1
Phase 4
Active: 3Recruiting: 2Completed: 3
Active Trials (5)
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
NCT03927261Acute Myeloid Leukemia
Phase 1Active
Enrollment: 88 participants
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
NCT04724980Recurrent Respiratory Papillomatosis
Phase 1Phase 2Active
Enrollment: 38 participants
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT03907527Platinum-Resistant Fallopian Tube Carcinoma
Phase 1Active
Enrollment: 71 participants
Zopa Retreatment and Vector Shedding in Adults With RRP
NCT06538480Recurrent Respiratory Papillomatosis
Phase 4Recruiting
Enrollment: 30 participants
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
NCT06157151Cervical Cancer
Phase 2Recruiting
Enrollment: 24 participants
BioScore
3.6/10
Cautious
Ownership
Recent Insider Trades
Thomasian Harry Jr.SELL
2026-07-01200,000 shares @ $5.57
Shah Rutul RSELL
2026-06-2942,924 shares @ $5.85
Sabzevari HelenSELL
2026-06-29346,836 shares @ $5.89
Thomasian Harry Jr.SELL
2026-05-2841,884 shares @ $4.36
Tennant PhilSELL
2026-05-2830,272 shares @ $4.36
Recent News
2026-07-02 00:02:48
2026-06-18 18:00:20
Data last updated: Jul 13, 2026, 12:44 PM